Thomas Bartrum Sells 2,252 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum sold 2,252 shares of the business’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $41,481.84. Following the completion of the transaction, the executive vice president now owns 103,862 shares of the company’s stock, valued at approximately $1,913,138.04. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Privia Health Group Stock Up 1.8 %

Shares of NASDAQ PRVA opened at $18.74 on Friday. Privia Health Group, Inc. has a twelve month low of $17.54 and a twelve month high of $30.15. The stock has a market cap of $2.22 billion, a price-to-earnings ratio of 98.64, a P/E/G ratio of 2.52 and a beta of 0.81. The company’s fifty day moving average is $19.64 and its 200-day moving average is $21.14.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.02). Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. The business had revenue of $440.80 million for the quarter, compared to analyst estimates of $425.81 million. During the same period in the previous year, the business posted $0.14 EPS. The business’s quarterly revenue was up 21.0% compared to the same quarter last year. On average, research analysts anticipate that Privia Health Group, Inc. will post 0.26 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Jefferies Financial Group assumed coverage on Privia Health Group in a research note on Monday, February 26th. They issued a “buy” rating and a $25.00 target price for the company. UBS Group dropped their price objective on Privia Health Group from $31.00 to $29.00 and set a “buy” rating for the company in a report on Friday, March 1st. Evercore ISI reduced their target price on shares of Privia Health Group from $26.00 to $25.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 28th. Citigroup initiated coverage on shares of Privia Health Group in a research note on Monday, April 22nd. They set a “buy” rating and a $25.00 price target for the company. Finally, JPMorgan Chase & Co. cut their price objective on shares of Privia Health Group from $38.00 to $30.00 and set an “overweight” rating on the stock in a report on Wednesday, March 6th. Two equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $27.62.

Hedge Funds Weigh In On Privia Health Group

Several institutional investors have recently modified their holdings of PRVA. Norges Bank bought a new stake in Privia Health Group during the 4th quarter worth approximately $27,959,000. Riverbridge Partners LLC increased its position in shares of Privia Health Group by 17.5% during the first quarter. Riverbridge Partners LLC now owns 5,399,662 shares of the company’s stock worth $105,779,000 after acquiring an additional 804,304 shares in the last quarter. Avidity Partners Management LP raised its holdings in shares of Privia Health Group by 43.1% during the third quarter. Avidity Partners Management LP now owns 1,545,100 shares of the company’s stock worth $35,537,000 after acquiring an additional 465,294 shares during the period. Northern Trust Corp lifted its position in Privia Health Group by 28.7% in the 3rd quarter. Northern Trust Corp now owns 1,344,327 shares of the company’s stock valued at $30,920,000 after acquiring an additional 299,395 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in Privia Health Group by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 11,278,334 shares of the company’s stock valued at $259,740,000 after acquiring an additional 274,345 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.